SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is seeing intense investor focus fueled by a series of strategic acquisitions, including the purchase of Indo Earth Moving Ltd., and a high-profile partnership with Palantir that reinforces its status as an emerging leader in autonomous defense and drone technology. The community remains heavily bullish, with traders actively debating the impact of upcoming earnings, potential government contract wins, and the stock's significant short interest as it navigates high volatility.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is experiencing intense volatility and speculative fervor following its IPO, driven by investor excitement over its military-grade drone swarm software and its perceived role in modern autonomous warfare. The community is actively debating the stock's long-term sustainability, with some traders anticipating a massive short-term squeeze due to the small float, while others express caution regarding the company's limited revenue and high-risk IPO nature.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is surging as investors bet on an AI-driven memory super-cycle, fueled by the company's high-volume production of HBM4 memory for Nvidia's new Vera Rubin platform and anticipation of its upcoming earnings report. The community is actively debating whether these gains are already priced in or if the stock is poised for further breakout as it prepares for inclusion in the S&P 100.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing intense trading activity as investors bet on a persistent multi-year memory shortage and sustained AI-driven demand, fueling discussions of a potential parabolic run or an impending rug pull. While some traders are aggressively shorting the stock, citing extreme valuations, others are focused on its correlation with memory sector leaders like Micron and anticipation surrounding upcoming industry conferences.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors digest news of a strategic collaboration with Samsung for HBM4 AI memory and potential foundry partnerships, while the community remains hyper-focused on how these supply chain moves position the company to compete against Nvidia. Market participants are debating whether this momentum can sustain a breakout above key technical levels, with sentiment divided between bullish expectations for long-term AI market share gains and skepticism regarding current valuations.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending following a positive clinical update reporting a continued reduction in recurrence rates within the open-label arm of its Phase III FLAMINGO-01 trial, with community sentiment buoyed by the company's manufacturing progress and the involvement of a high-profile steering committee. Investors are actively discussing the significance of the upcoming AACR presentation, with many viewing the stock as a de-risked opportunity as they anticipate further data catalysts and potential institutional interest.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is trending as investors weigh strong quarterly earnings and an optimistic growth outlook against volatility in the memory sector, with the community actively debating whether the storage demand driven by AI data centers justifies the stock's recent rally or if a cooling period is inevitable. While bullish traders point to successful debt management and strategic alignment with sector peers like SanDisk, others are closely monitoring supply chain constraints and cautious about potential profit-taking following a period of rapid appreciation.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance remains a focal point for investors as the community debates the long-term impact of its debt-heavy acquisition of Warner Bros. Discovery and the transition to a unified, tech-focused media strategy. While some investors see the deal as a transformative move that creates a content powerhouse, others are expressing concern over the significant debt load and the recent credit rating downgrades to junk status.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors weigh significant analyst downgrades and concerns over the saturation of the obesity drug market against the company's strong long-term pipeline potential and clinical leadership. The community remains deeply divided, with some traders taking short positions to capitalize on technical resistance while others treat the price dip as a buying opportunity in anticipation of upcoming oral drug approvals.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is seeing high trading volume and intense debate among investors as they track upcoming regulatory milestones and weigh the company's pre-revenue status against its long-term potential in nuclear energy. The community is actively discussing the stock's recent price volatility, insider activity, and the impact of the broader nuclear energy narrative on its future valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SANA This author has been pretty good about reporting on Sana. 
+:&quot;The clinical data not only suggest the possibility of a functional cure but also de-risk/validate its approach to escaping immune destruction, which could have applications across many indications.&quot;  
 
-:&quot;That said, it will have to continue to dilute shareholders over the foreseeable future, possibly at a much higher share price.&quot; 
https://seekingalpha.com/article/4869957-sana-biotechnology-small-speculative-play

Sudhakar Andaluri

Mirko papuga

Nick Lee

KnysnaNow

robert

Seekingalpha

StockTwits Web

Sana Biotechnology Inc

 This author has been pretty good about reporting on Sana. 
+:"The clinical data not only suggest the possibility of a functional cure but also de-risk/validate its approach to escaping immune destruction, which could have applications across many indications."  
 
-:"That said, it will have to continue to dilute shareholders over the foreseeable future, possibly at a much higher share price." 


Dexcom Inc

Vertex Pharmaceuticals, Inc.

Eledon Pharmaceuticals Inc

Sensei Biotherapeutics Inc

iSpecimen Inc

Brian H.

@BriOnH I really don’t believe the majority of investors generally understand how difficult this problem is to solve, and how significant Sana’s progress has been. They seem to view it as just another drug development story. “Why do they need so much money for this ‘drug’??” “Diluting means they’re just burning money foolishly!” Anyone with a shred of understanding should know that an immunosuppressant-free treatment for an autoimmune disease is going to cost A LOT. And no, we don’t know how much because it’s never been done before! They don’t give enough weight to the other side of the equation: the payoff in the success lasts literally forever, thousands of new T1s are born every day all around the world and will continue to be born every day, forever. And it begins with a TAM of almost 10 million. Thanks for coming to my Ted Talk.

Humdinger 1966

Bob Knob

StockTwits for iOS

 I really don’t believe the majority of investors generally understand how difficult this problem is to solve, and how significant Sana’s progress has been. They seem to view it as just another drug development story. “Why do they need so much money for this ‘drug’??” “Diluting means they’re just burning money foolishly!” Anyone with a shred of understanding should know that an immunosuppressant-free treatment for an autoimmune disease is going to cost A LOT. And no, we don’t know how much because it’s never been done before! They don’t give enough weight to the other side of the equation: the payoff in the success lasts literally forever, thousands of new T1s are born every day all around the world and will continue to be born every day, forever. And it begins with a TAM of almost 10 million. Thanks for coming to my Ted Talk.

jdogg

@jaykalope I hear you Jay, 100%.  I did not think hypoimmune cells would be developed in my lifetime.  I thought it was going to be some miraculous encapsulation material that would eventually get us to where we need to be, and hypoimmune was 50 years away at best.  Yet Sana cracked it. They will forever be etched in history as putting allogenic cells into a human without the need for IS.  It is a monumental achievement.    
  
That being said I&#39;d be lying if I said money isn&#39;t a big concern, especially if a major hiccup happens, and manufacturing is another big one I think about often too, but that&#39;s all out of my hands.  Right now I just pray for more good clinical results and a clean path forward.

 I hear you Jay, 100%.  I did not think hypoimmune cells would be developed in my lifetime.  I thought it was going to be some miraculous encapsulation material that would eventually get us to where we need to be, and hypoimmune was 50 years away at best.  Yet Sana cracked it. They will forever be etched in history as putting allogenic cells into a human without the need for IS.  It is a monumental achievement.    
  
That being said I'd be lying if I said money isn't a big concern, especially if a major hiccup happens, and manufacturing is another big one I think about often too, but that's all out of my hands.  Right now I just pray for more good clinical results and a clean path forward.